Clinical Trial Update: PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a phosphodiesterase inhibitor in patients with pulmonary hypertension undergoing mitral valve surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Snippet

Sponsor: Dr. Robert Klempfner Heart Rehabilitation Institute | Conditions: Pulmonary Hypertension, Mitral Valve Surgery | Phase 4 | Status: COMPLETED